New study eyes monthly virus tests to shield transplant kidneys
NCT ID NCT07393594
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 1000 kidney transplant patients for one year to see if monthly blood tests for certain viruses (CMV, BK, and TTV) can help predict and prevent serious infections and kidney damage. The goal is to learn how the body's immune system and virus levels relate to transplant outcomes, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BK VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can cord blood t cells be trained to stop viral infections after transplant?
- Could a pill shield the brain and kidneys during heart surgery?
- Can specially grown immune cells from donors beat viruses that won't go away?
- Blood test could tailor CMV prevention after stem cell transplants
- Contrast dye Double-Dose: new study tracks kidney fallout in ICU patients
- Could a simple breath test spot hidden diseases early?